A free, on-demand webinar from the artificial intelligence (AI) experts involved in developing the recently released from the 黑料网 (黑料网 DSI) shares how to evaluate the 111 commercial algorithms currently available and what to consider in evaluating an algorithm.
Topics include:
- Background on the U.S. Food and Drug Administration (FDA) clearance process and where to find links to the FDA clearance letter for the algorithms listed in the catalog, including background information on risk assessment, device category, use designation and approval pathway.
- An overview of tools developed by 黑料网 DSI for AI performance monitoring, including , and .
- Discussion of areas of concern for AI products, such as AI brittleness or robustness.
- Step-by-step guidance on how to use the FDA-Cleared Algorithm Catalog to find algorithms that may be a good fit for your practice.
The on-demand webinar was developed from a live event held March 3, 2021. now or on future AI-related events.